These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 21280316)

  • 41. [Association of serum HBV DNA level with cytotoxic T lymphocytes in patients with HBV-induced hepatic cirrhosis].
    Gu XB; Yang XJ; Wang D; Hua Z; Xu YQ; Lu ZH
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Oct; 24(5):327-30. PubMed ID: 21280314
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Elevated CA 125 in chronic liver disease with ascites].
    Crespo Valadés E; Malmierca Corral M
    Gastroenterol Hepatol; 2004 Nov; 27(9):558. PubMed ID: 15544744
    [No Abstract]   [Full Text] [Related]  

  • 43. Clinical characteristics and outcome of patients with cirrhosis and refractory ascites.
    Moreau R; Delègue P; Pessione F; Hillaire S; Durand F; Lebrec D; Valla DC
    Liver Int; 2004 Oct; 24(5):457-64. PubMed ID: 15482343
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical significance of elevated alpha-fetoprotein (AFP) in chronic hepatitis C without hepatocellular carcinoma.
    Chen CH; Lin ST; Kuo CL; Nien CK
    Hepatogastroenterology; 2008; 55(85):1423-7. PubMed ID: 18795704
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aminoterminal propeptide of type III procollagen in serum in alcoholic liver disease.
    Niemelä O; Risteli L; Sotaniemi EA; Risteli J
    Gastroenterology; 1983 Aug; 85(2):254-9. PubMed ID: 6602726
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
    Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
    Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The value of serum CA 125 for monitoring treatment of patients with ovarian cancer].
    Zaucha R; Kobierska A
    Przegl Lek; 1995; 52(2):51-3. PubMed ID: 7784616
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Variations of serum sialic acid level in liver cirrhosis.
    Arif S; Najeeb-ul-Haq ; Hanif R; Khan AS; Jamil-ur-Rehman ; Mufti TA
    J Ayub Med Coll Abbottabad; 2005; 17(3):54-7. PubMed ID: 16320799
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
    D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
    Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma.
    Romeo R; Del Ninno E; Rumi M; Russo A; Sangiovanni A; de Franchis R; Ronchi G; Colombo M
    Gastroenterology; 2009 May; 136(5):1629-38. PubMed ID: 19208358
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Usefulness of non-invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B.
    Lee KG; Seo YS; An H; Um SH; Jung ES; Keum B; Yim HJ; Jeen YT; Chun HJ; Kim CD; Ryu HS
    J Gastroenterol Hepatol; 2010 Jan; 25(1):94-100. PubMed ID: 19793171
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preoperative serum CA-125 levels in treating endometrial cancer.
    Powell JL; Hill KA; Shiro BC; Diehl SJ; Gajewski WH
    J Reprod Med; 2005 Aug; 50(8):585-90. PubMed ID: 16220763
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Benign ovarian fibroma associated with free peritoneal fluid and elevated serum CA 125 levels.
    Spinelli C; Gadducci A; Bonadio AG; Berti P; Miccoli P
    Minerva Ginecol; 1999 Oct; 51(10):403-7. PubMed ID: 10638167
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum and ascites levels of macrophage migration inhibitory factor, TNF-alpha and IL-6 in patients with chronic virus hepatitis B and hepatitis cirrhosis.
    Zhang W; Yue B; Wang GQ; Lu SL
    Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):577-80. PubMed ID: 14607690
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis.
    Yilmaz S; Bayan K; Tüzün Y; Dursun M; Kaplan A; Ozmen S; Canoruç F; Akkuş Z
    Int J Clin Pract; 2007 Mar; 61(3):438-43. PubMed ID: 17313611
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elevation of CA-125 level is due to abdominal distension in liver transplantation candidates.
    Deschênes M; Michel RP; Alpert E; Barkun JS; Metrakos P; Tchervenkov J
    Transplantation; 2001 Nov; 72(9):1519-22. PubMed ID: 11707739
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Authors reply.
    Qureshi MO; Dar FS; Khokhar N
    J Coll Physicians Surg Pak; 2014 Nov; 24(11):873-4. PubMed ID: 25556262
    [No Abstract]   [Full Text] [Related]  

  • 59. Elevation of CA 125 and CA 19-9 in patients with end-stage liver disease.
    Singhal A; Lander E; Karachristos A; Daly E; Dowling P; Patel V; Maloo M; Jain A
    Int J Biol Markers; 2012 Jul; 27(2):e147-51. PubMed ID: 22467099
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The term "tumor marker" under revision. Report of a patient demonstrating such need (liver cirrhosis and CA 12.5)].
    Bataller Sifré R; Guiral Olivan V; Fernández Rodríguez C; Tormo Bataller R; Rosique Martínez A
    Rev Esp Enferm Dig; 2008 Nov; 100(11):734-6. PubMed ID: 19159183
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.